HMOX1 and endothelial dysfunction: The third experiment demonstrated that PETN did not improve endothelial dysfunction and cardiac oxidative stress in angiotensin-II-(low-dose) treated HO-1+/− mice but further impaired vascular function and increased ROS formation in this setting (Figure 2(e) and 2(f)).